Melissa V. Rewolinski's most recent trade in Arbutus Biopharma Corp was a trade of 67,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on May 23, 2024.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Arbutus Biopharma Corp | Melissa V. Rewolinski | Director | 23 May 2024 | 67,000 | 67,000 | - | - | Stock Option (Right to Buy) | ||
| Arbutus Biopharma Corp | Melissa V. Rewolinski | Director | 12 Jul 2023 | 110,000 | 110,000 | - | - | Stock Option (Right to Buy) |